Featured Research

from universities, journals, and other organizations

How Parkinson's Develops: Protein Found That Regulates Gene Critical To Dopamine-releasing Brain Cells

Date:
September 11, 2008
Source:
Georgetown University Medical Center
Summary:
Researchers have identified a protein they say appears to be a primary player in maintaining normal functioning of an important class of neurons -- those brain cells that produce, excrete and then reabsorb dopamine neurotransmitters. These molecules command numerous body functions, ranging from management of behavior and mood to control of movement, and one day may hold the key to why and how some people develop Parkinson's and other brain diseases.

Researchers have identified a protein they say appears to be a primary player in maintaining normal functioning of an important class of neurons – those brain cells that produce, excrete and then reabsorb dopamine neurotransmitters. These molecules command numerous body functions, ranging from management of behavior and mood to control of movement, and one day may hold the key to why and how some people develop Parkinson's and other brain diseases.

In the September 10 issue of the Journal of Neuroscience, the scientists say that this protein, which they call the Nurr-1 interacting protein (NuIP), interacts with, and helps regulate the activity of the Nurr1 gene. That gene has long been known to be essential to development and maintenance of dopaminergic neurons.

Efforts to control Nurr-1 have been underway by pharmaceutical drug developers, because these neurons are the ones that die in Parkinson's disease and which are, conversely, over-active in schizophrenia. Now NuIP may also provide a good drug target for these and other neurological disorders caused by faulty dopamine transmission, says the study's lead investigator, Howard J. Federoff, M.D., Ph.D., Executive Vice President for Health Sciences and Executive Dean of the School of Medicine at Georgetown University Medical Center.

"We do not know yet whether this is true, but one can speculate that small molecules that may either facilitate, stabilize, or otherwise regulate the action of NuIP on Nurr1 may be relevant in a therapeutic context," says Federoff, a neuroscientist who did much of this research at the University of Rochester School of Medicine and Dentistry before coming to Georgetown in 2007. His three other co-authors are from Rochester.

In this study, the researchers specifically set out to find potential "partners" of Nurr1 because no molecule had yet been found that could positively activate the Nurr1 gene or the protein receptor it produces. Crystal structures of the Nurr1 receptor show it to have an area where another protein could bind to it, but this "domain" is too small for usual binding partners, such as steroids.

Using a library of potential molecules in laboratory samples of brain cells from a developing mouse, the researchers identified a new family of gene products that interacts with and regulates the activity of Nurr1. These gene products are all derived from the NuIP gene.

They then discovered that loss of NuIP function led to decreased numbers of cells in culture and to a decreased expression of the dopamine transporter on these neurons.

The mechanism underlying the ability of NuIP to positively regulate the activity of Nurr1 is not yet clear, but the researchers suspect that "as yet unknown upstream signals impinge on NuIP which, in turn, instructs Nurr1 to become activated and thus facilitates the expression of a set of genes involved in dopamine neuron phenotypic maturation," Federoff says. "That means they become more like a dopamine neuron which manufactures, releases, and the takes up the neurotransmitter."

"The relevance of NuIP to Parkinson's disease has not been established but it is tempting to speculate that it participates in the maintenance of the mature phenotype of midbrain dopaminergic neurons which are rendered vulnerable in this neurological disease," Federoff says.

The study was supported by grants from the Department of Defense.


Story Source:

The above story is based on materials provided by Georgetown University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Georgetown University Medical Center. "How Parkinson's Develops: Protein Found That Regulates Gene Critical To Dopamine-releasing Brain Cells." ScienceDaily. ScienceDaily, 11 September 2008. <www.sciencedaily.com/releases/2008/09/080910090618.htm>.
Georgetown University Medical Center. (2008, September 11). How Parkinson's Develops: Protein Found That Regulates Gene Critical To Dopamine-releasing Brain Cells. ScienceDaily. Retrieved April 16, 2014 from www.sciencedaily.com/releases/2008/09/080910090618.htm
Georgetown University Medical Center. "How Parkinson's Develops: Protein Found That Regulates Gene Critical To Dopamine-releasing Brain Cells." ScienceDaily. www.sciencedaily.com/releases/2008/09/080910090618.htm (accessed April 16, 2014).

Share This



More Health & Medicine News

Wednesday, April 16, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Even Casual Marijuana Use Alter Your Brain?

Could Even Casual Marijuana Use Alter Your Brain?

Newsy (Apr. 16, 2014) A new study conducted by researchers at Northwestern and Harvard suggests even casual marijuana use can alter your brain. Video provided by Newsy
Powered by NewsLook.com
Ebola Outbreak Now Linked To 121 Deaths

Ebola Outbreak Now Linked To 121 Deaths

Newsy (Apr. 15, 2014) The ebola virus outbreak in West Africa is now linked to 121 deaths. Health officials fear the virus will continue to spread in urban areas. Video provided by Newsy
Powered by NewsLook.com
Cognitive Function: Is It All Downhill From Age 24?

Cognitive Function: Is It All Downhill From Age 24?

Newsy (Apr. 15, 2014) A new study out of Canada says cognitive motor performance begins deteriorating around age 24. Video provided by Newsy
Powered by NewsLook.com
How Mt. Everest Helped Scientists Research Diabetes

How Mt. Everest Helped Scientists Research Diabetes

Newsy (Apr. 15, 2014) British researchers were able to use Mount Everest's low altitudes to study insulin resistance. They hope to find ways to treat diabetes. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins